Quale sarebbe il prezzo per Thalia Therapeutics Plc (THAT)

Il prezzo per Thalia Therapeutics Plc (THAT) è $0.00918474

Qual è la capitalizzazione di mercato per Thalia Therapeutics Plc (THAT)

La capitalizzazione di mercato per Thalia Therapeutics Plc (THAT) è $76.44K

Thalia Therapeutics Plc (THAT) Prezzo e Capitalizzazione di Mercato

Thalia Therapeutics Plc, a specialized pharmaceutical company established in 1979 and headquartered in Chellaston, UK, focuses on developing advanced nanoparticle silica delivery systems. These innovative systems are designed to enhance the cellular uptake and effectiveness of various cancer treatments and vaccines. The company's product portfolio includes Nuvec, a unique silica nanoparticle delivery platform distinguished by its irregular surface structure that effectively encapsulates and safeguards genetic material such as siRNA, RNA, and DNA. Additionally, it offers Liptide, a specialized platform engineered for the targeted delivery of a proprietary siRNA sequence to silence fibrotic genes. Thalia Therapeutics is also advancing N4 101, an orally administered inflammation inhibitor currently undergoing pre-clinical evaluation for the treatment of inflammatory bowel disease, alongside ECP105, which is being developed to prevent ocular scarring. The firm, previously known as N4 Pharma Plc, officially rebranded to Thalia Therapeutics Plc in March 2026.

Il prezzo per THAT	Attivo B	Capitalizzazione del mercato a B	Risultati
$656,774 $76.44K	NVDA	$5.466T	+7,150,707,408.58%
$538,149 $76.44K	AAPL	$4.479T	+5,859,170,517.36%
$501,721 $76.44K	GOOG	$4.176T	+5,462,549,480.71%
$443,313 $76.44K	MSFT	$3.690T	+4,826,630,127.09%
$346,296 $76.44K	AMZN	$2.882T	+3,770,339,203.72%

Il prezzo per THAT

Attivo B

Capitalizzazione del mercato a B

Risultati

$656,774 $76.44K